98
Views
39
CrossRef citations to date
0
Altmetric
Original Research

Anti-transferrin receptor-modified amphotericin B-loaded PLA–PEG nanoparticles cure Candidal meningitis and reduce drug toxicity

, , , , , , , , , , , , , & show all
Pages 6227-6241 | Published online: 05 Oct 2015

References

  • YuYDuLYuanTRisk factors and clinical analysis for invasive fungal infection in neonatal intensive care unit patientsAm J Perinatol201330758959423277386
  • PostMJThurnherMMCliffordDBCNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 2: discussion of neuroimmune reconstitution inflammatory syndrome with and without other pathogensAJNR Am J Neuroradiol20133471308131822790252
  • BadieePKordbachehPAlborziAZeiniFMirhendyHMahmoodyMFungal infections in solid organ recipientsExp Clin Transplant20053238538916417449
  • PettitACKropskiJACastilhoJLThe index case for the fungal meningitis outbreak in the United StatesN Engl J Med2012367222119212523083311
  • ShaoKWuJChenZA brain-vectored angiopep-2 based polymeric micelles for the treatment of intracranial fungal infectionBiomaterials201233286898690722789719
  • TribbleDRRodriguezCJCombat-related invasive fungal wound infectionsCurr Fungal Infect Rep20148427728625530825
  • AzikFMTezerHParlakayAOSecondary antifungal prophylaxis in pediatric hematopoietic stem cell transplantsJ Pediatr Hematol Oncol2015371e19e2225522351
  • MohamadiJMotaghiMPanahiJAnti-fungal resistance in candida isolated from oral and diaper rash candidiasis in neonatesBioinformation2014101166767025512681
  • AntunesAMTeixeiraCCorvoMLPerdigotoRBarrosoEMarcelinoPProphylactic use of liposomal amphotericin B in preventing fungal infections early after liver transplantation: a retrospective, single-center studyTransplant Proc201446103554355925498088
  • KassabRParrot-LopezHFessiHMenaucourtJBonalyRCoulonJMolecular recognition by Kluyveromyces of amphotericin B-loaded, galactosetagged, poly(lactic acid) microspheresBioorg Med Chem20021061767177511937335
  • ZhouWWangYJianJSongSSelf-aggregated nanoparticles based on amphiphilic poly(lactic acid)-graftedchitosan copolymer for ocular delivery of amphotericin BInt J Nanomedicine201383715372824106427
  • RenTXuNCaoCPreparation and therapeutic efficacy of polysorbate-80-coated amphotericin B/PLA-b-PEG nanoparticlesJ Biomater Sci Polym Ed200920101369138019622277
  • LipaSSunitaYMansoorANanotechnology for CNS delivery of bio-therapeutic agentsDrug Deliv Transl Res20133433635123894728
  • KimKYuMZongXControl of degradation rate and hydrophilicity in electrospun non-woven poly(d, l-lactide) nanofiber scaffolds for biomedical applicationsBiomaterials200324274977498514559011
  • GabizonAHorowitzATGorenDTargeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studiesBioconjug Chem199910228929810077479
  • BlancoElvinBeyErik ADongYingβ-Lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cellsJ Control Release2007122336537417574288
  • KarimSSMahmoudESLucaCDetermination of factors controlling the particle size and entrapment efficiency of noscapine in PEG/PLA nanoparticles using artificial neural networksInt J Nanomedicine201494953496425364252
  • TangXDaiHZhuYMaytansine-loaded star-shaped folatecore PLA-TPGS nanoparticles enhancing anticancer activityAm J Transl Res20146552853725360217
  • SadeHBaumgartnerCHugenmatterAMoessnerEFreskgårdPONiewoehnerJA human blood-brain barrier transcytosis assay reveals antibody transcytosis influenced by pH-dependent receptor bindingPLoS One201494e9634024788759
  • BansalVKumarMDalelaMBrahmneHGSinghHEvaluation of synergistic effect of biodegradable polymeric nanoparticles and aluminum based adjuvant for improving vaccine efficacyInt J Pharm20144711–237738424939616
  • YamasakiMHaradaETamuraYIn vitro and in vivo safety and efficacy studies of amphotericin B on Babesia gibsoniVet Parasitol20142053–442443325260334
  • ShimadaCUesawaYIshiharaMQuantitative structure-cytotoxicity relationship of piperic acid amidesAnticancer Res20143494877488425202069
  • CapillaJFlaviaAMayayoEGuarroJEfficacy of intrathecal liposomal amphotericin B plus oral posaconazole in the treatment of acute meningeal cryptococcosis in a murine modelInt J Antimicrob Agents201342328228323845502
  • O’ConnorLLivermoreJSharpADPharmacodynamics of liposomal amphotericin B and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patientsJ Infect Dis2013208235136123599314
  • UrbschatAObermüllerNPaulusPUpper and lower urinary tract infections can be detected early but not be discriminated by urinary NGAL in adultsInt Urol Nephrol201446122243224925218613
  • MartinsSMSarmentoBNunesCLúcioMReisSFerreiraDCBrain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administrationEur J Pharm Biopharm2013853 Pt A48850223994244
  • BoothRKimHPermeability analysis of neuroactive drugs through a dynamic microfluidic in vitro blood-brain barrier modelAnn Biomed Eng201442122379239125118670
  • MolinoYJabèsFLacassagneEGaudinNKhrestchatiskyMSetting-up an in vitro model of rat blood-brain barrier (BBB): a focus on BBB impermeability and receptor-mediated transportJ Vis Exp201488e5127824998179
  • ChuHDingHTangYDongQErythropoietin protects against hemorrhagic blood-brain barrier disruption through the effects of aquaporin-4Lab Invest20149491042105324978642
  • PetraitieneRPetraitisVLymanCAEfficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbitsAntimicrob Agents Chemother20044841188119615047519